Net profit of Medicamen Biotech rose 44.58% to Rs 3.47 crore in the quarter ended December 2024 as against Rs 2.40 crore during the previous quarter ended December 2023. Sales declined 2.92% to Rs 45.14 crore in the quarter ended December 2024 as against Rs 46.50 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended |
| Dec. 2024 | Dec. 2023 | % Var. |
| Sales | 45.14 | 46.50 | -3 |
| OPM % | 14.86 | 10.52 | - |
| PBDT | 6.09 | 5.08 | 20 |
| PBT | 3.88 | 3.27 | 19 |
| NP | 3.47 | 2.40 | 45 |